Repository logo
 

Quantitative Proteomics Analysis of Lytic KSHV Infection in Human Endothelial Cells Reveals Targets of Viral Immune Modulation.

Published version
Peer-reviewed

Change log

Authors

Gabaev, Ildar 
Williamson, James C 
Crozier, Thomas WM 
Schulz, Thomas F 
Lehner, Paul J 

Abstract

Kaposi's sarcoma herpesvirus (KSHV) is an oncogenic human virus and the leading cause of mortality in HIV infection. KSHV reactivation from latent- to lytic-stage infection initiates a cascade of viral gene expression. Here we show how these changes remodel the host cell proteome to enable viral replication. By undertaking a systematic and unbiased analysis of changes to the endothelial cell proteome following KSHV reactivation, we quantify >7,000 cellular proteins and 71 viral proteins and provide a temporal profile of protein changes during the course of lytic KSHV infection. Lytic KSHV induces >2-fold downregulation of 291 cellular proteins, including PKR, the key cellular sensor of double-stranded RNA. Despite the multiple episomes per cell, CRISPR-Cas9 efficiently targets KSHV genomes. A complementary KSHV genome-wide CRISPR genetic screen identifies K5 as the viral gene responsible for the downregulation of two KSHV targets, Nectin-2 and CD155, ligands of the NK cell DNAM-1 receptor.

Description

Keywords

HHV-8, KSHV, NK cell receptor ligands, herpesvirus, host cell restriction factors, lytic reactivation, proteomics, viral immune evasion, Antigens, Differentiation, T-Lymphocyte, Cell Line, DNA-Directed DNA Polymerase, Down-Regulation, Endothelial Cells, Gene Library, Gene Ontology, Genes, Viral, Genetic Testing, Herpesvirus 8, Human, Humans, Immunomodulation, Kinetics, Ligands, Mutation, Proteome, Proteomics, Sarcoma, Kaposi, Up-Regulation, Viral Proteins, Virus Activation, eIF-2 Kinase

Journal Title

Cell Rep

Conference Name

Journal ISSN

2211-1247
2211-1247

Volume Title

33

Publisher

Elsevier BV
Sponsorship
European Commission (656511)
Medical Research Council (MR/R001405/1)
Wellcome Trust (210688/Z/18/Z)
Horizon 2020/grant agreement no. 656511 Deutsche Forschungsgemeinschaft – SFB900/3 – 158989968; project C1.